Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2808.0
(2.3%)
JPY 2808.0
(2.3%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 16.17 Billion JPY | 634.8% |
| 2022 | 2.2 Billion JPY | -86.17% |
| 2021 | 15.91 Billion JPY | 14.01% |
| 2020 | 13.95 Billion JPY | -3.76% |
| 2019 | 14.5 Billion JPY | 7.63% |
| 2018 | 13.47 Billion JPY | 107.47% |
| 2017 | 6.49 Billion JPY | 16.48% |
| 2016 | 5.57 Billion JPY | -27.43% |
| 2015 | 7.68 Billion JPY | -30.89% |
| 2014 | 11.11 Billion JPY | 85.55% |
| 2013 | 5.99 Billion JPY | -3.37% |
| 2012 | 6.2 Billion JPY | 8.09% |
| 2011 | 5.73 Billion JPY | -1.86% |
| 2010 | 5.84 Billion JPY | 27.03% |
| 2009 | 4.6 Billion JPY | 21.84% |
| 2008 | 3.77 Billion JPY | 40.27% |
| 2007 | 2.69 Billion JPY | 3.65% |
| 2006 | 2.59 Billion JPY | 156.64% |
| 2005 | 1.01 Billion JPY | -49.07% |
| 2004 | 1.98 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 5.49 Billion JPY | 18.05% |
| 2023 Q1 | 4.75 Billion JPY | 2088.94% |
| 2023 FY | 16.17 Billion JPY | 634.8% |
| 2023 Q4 | 4.65 Billion JPY | 1.97% |
| 2023 Q3 | 4.56 Billion JPY | 107.22% |
| 2023 Q2 | 2.2 Billion JPY | -53.62% |
| 2022 FY | 2.2 Billion JPY | -86.17% |
| 2022 Q4 | 217 Million JPY | 130.65% |
| 2022 Q2 | 1.29 Billion JPY | -7.03% |
| 2022 Q1 | 1.39 Billion JPY | 52.63% |
| 2022 Q3 | -708 Million JPY | -154.59% |
| 2021 Q4 | 914 Million JPY | -84.13% |
| 2021 Q2 | 3.93 Billion JPY | -25.98% |
| 2021 Q3 | 5.75 Billion JPY | 46.48% |
| 2021 Q1 | 5.31 Billion JPY | 17.73% |
| 2021 FY | 15.91 Billion JPY | 14.01% |
| 2020 Q2 | 2.91 Billion JPY | -12.56% |
| 2020 Q1 | 3.33 Billion JPY | -5.63% |
| 2020 FY | 13.95 Billion JPY | -3.76% |
| 2020 Q4 | 4.51 Billion JPY | 41.15% |
| 2020 Q3 | 3.19 Billion JPY | 9.6% |
| 2019 Q1 | 3.76 Billion JPY | 24.64% |
| 2019 Q3 | 3.9 Billion JPY | 18.2% |
| 2019 Q2 | 3.3 Billion JPY | -12.27% |
| 2019 FY | 14.5 Billion JPY | 7.63% |
| 2019 Q4 | 3.53 Billion JPY | -9.45% |
| 2018 Q1 | 3.56 Billion JPY | 506.15% |
| 2018 Q2 | 2.61 Billion JPY | -26.78% |
| 2018 FY | 13.47 Billion JPY | 107.47% |
| 2018 Q4 | 3.02 Billion JPY | -29.41% |
| 2018 Q3 | 4.27 Billion JPY | 63.85% |
| 2017 Q1 | 2 Billion JPY | 159.72% |
| 2017 Q4 | -878 Million JPY | -128.6% |
| 2017 FY | 6.49 Billion JPY | 16.48% |
| 2017 Q3 | 3.07 Billion JPY | 33.59% |
| 2017 Q2 | 2.29 Billion JPY | 14.61% |
| 2016 Q3 | 4.71 Billion JPY | 298.56% |
| 2016 Q2 | 1.18 Billion JPY | 207.73% |
| 2016 FY | 5.57 Billion JPY | -27.43% |
| 2016 Q1 | -1.09 Billion JPY | -179.87% |
| 2016 Q4 | 772 Million JPY | -83.64% |
| 2015 Q3 | 2.29 Billion JPY | 29.31% |
| 2015 Q1 | 2.24 Billion JPY | 1.22% |
| 2015 FY | 7.68 Billion JPY | -30.89% |
| 2015 Q4 | 1.37 Billion JPY | -40.02% |
| 2015 Q2 | 1.77 Billion JPY | -20.8% |
| 2014 Q1 | 1.28 Billion JPY | 50.29% |
| 2014 FY | 11.11 Billion JPY | 85.55% |
| 2014 Q4 | 2.21 Billion JPY | -54.25% |
| 2014 Q3 | 4.83 Billion JPY | 73.62% |
| 2014 Q2 | 2.78 Billion JPY | 117.32% |
| 2013 Q4 | 853 Million JPY | -72.66% |
| 2013 FY | 5.99 Billion JPY | -3.37% |
| 2013 Q1 | 1.19 Billion JPY | -0.33% |
| 2013 Q2 | 820 Million JPY | -31.61% |
| 2013 Q3 | 3.12 Billion JPY | 280.49% |
| 2012 Q1 | 1.36 Billion JPY | -2.15% |
| 2012 Q2 | 1.34 Billion JPY | -1.76% |
| 2012 FY | 6.2 Billion JPY | 8.09% |
| 2012 Q3 | 2.28 Billion JPY | 70.36% |
| 2012 Q4 | 1.2 Billion JPY | -47.42% |
| 2011 Q2 | 1.42 Billion JPY | -4.1% |
| 2011 Q1 | 1.48 Billion JPY | -3.06% |
| 2011 Q3 | 1.42 Billion JPY | -0.14% |
| 2011 Q4 | 1.39 Billion JPY | -1.96% |
| 2011 FY | 5.73 Billion JPY | -1.86% |
| 2010 Q4 | 1.53 Billion JPY | -8.03% |
| 2010 Q2 | 1.55 Billion JPY | 44.09% |
| 2010 Q1 | 1.08 Billion JPY | -13.54% |
| 2010 FY | 5.84 Billion JPY | 27.03% |
| 2010 Q3 | 1.66 Billion JPY | 7.06% |
| 2009 Q3 | 1.44 Billion JPY | 58.69% |
| 2009 FY | 4.6 Billion JPY | 21.84% |
| 2009 Q1 | 1 Billion JPY | -18.85% |
| 2009 Q4 | 1.25 Billion JPY | -13.1% |
| 2009 Q2 | 907.44 Million JPY | -9.53% |
| 2008 Q4 | 1.23 Billion JPY | 41.53% |
| 2008 Q1 | 862.95 Million JPY | 0.0% |
| 2008 FY | 3.77 Billion JPY | 40.27% |
| 2008 Q3 | 873.33 Million JPY | 8.51% |
| 2008 Q2 | 804.81 Million JPY | -6.74% |
| 2007 FY | 2.69 Billion JPY | 3.65% |
| 2006 FY | 2.59 Billion JPY | 156.64% |
| 2005 FY | 1.01 Billion JPY | -49.07% |
| 2004 FY | 1.98 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -404.618% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 88.774% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 105.135% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 90.019% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -14743.198% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 37.438% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | -101.533% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 61.862% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -2220.373% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | -15.778% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -255.685% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -1074.51% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 9085.0% |
| Tsumura & Co. | 16.7 Billion JPY | 3.196% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | -44.919% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -292.644% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -370.83% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | -109.19% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -203.89% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 430.466% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -390.835% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 923.969% |
| MedRx Co., Ltd | -932 Million JPY | 1835.3% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -328.51% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 1554.406% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 776.179% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -114.354% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | -18.094% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 2844.857% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 21.707% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -448.919% |